vs
First Northwest Bancorp（FNWB）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
First Northwest Bancorp的季度营收约是ROCKWELL MEDICAL, INC.的1.0倍（$18.4M vs $18.3M），First Northwest Bancorp净利率更高（2.6% vs -3.0%，领先5.6%），First Northwest Bancorp同比增速更快（19.1% vs -25.6%），过去两年First Northwest Bancorp的营收复合增速更高（6.8% vs -10.1%）
第一西北 Bancorp 相关主体前身为伊利诺伊州乔利埃特的金融机构，发展后业务覆盖芝加哥多个郊区、印第安纳州西北部、伊利诺伊州南部、威斯康星州东南部，以及包含爱荷华州的阔德城地区，旗下第一中西部银行是美国规模较大的银行业机构之一，总部位于伊利诺伊州芝加哥奥黑尔机场东侧。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
FNWB vs RMTI — 直观对比
营收规模更大
FNWB
是对方的1.0倍
$18.3M
营收增速更快
FNWB
高出44.7%
-25.6%
净利率更高
FNWB
高出5.6%
-3.0%
两年增速更快
FNWB
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.4M | $18.3M |
| 净利润 | $382.0K | $-554.0K |
| 毛利率 | — | 21.1% |
| 营业利润率 | 6.2% | -2.2% |
| 净利率 | 2.6% | -3.0% |
| 营收同比 | 19.1% | -25.6% |
| 净利润同比 | 113.6% | 26.7% |
| 每股收益（稀释后） | $0.04 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FNWBRMTI
| Q4 25 | $18.4M | $18.3M | ||
| Q3 25 | $16.6M | $15.9M | ||
| Q2 25 | $16.4M | $16.1M | ||
| Q1 25 | $17.6M | $18.9M | ||
| Q4 24 | $15.4M | $24.7M | ||
| Q3 24 | $15.8M | $28.3M | ||
| Q2 24 | $21.6M | $25.8M | ||
| Q1 24 | $16.1M | $22.7M |
净利润FNWBRMTI
| Q4 25 | $382.0K | $-554.0K | ||
| Q3 25 | $802.0K | $-1.8M | ||
| Q2 25 | $3.7M | $-1.5M | ||
| Q1 25 | $-9.0M | $-1.5M | ||
| Q4 24 | $-2.8M | $-756.0K | ||
| Q3 24 | $-2.0M | $1.7M | ||
| Q2 24 | $-2.2M | $343.0K | ||
| Q1 24 | $396.0K | $-1.7M |
毛利率FNWBRMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
营业利润率FNWBRMTI
| Q4 25 | 6.2% | -2.2% | ||
| Q3 25 | -0.9% | -9.9% | ||
| Q2 25 | 24.2% | -8.4% | ||
| Q1 25 | -57.7% | -7.2% | ||
| Q4 24 | -17.3% | -2.1% | ||
| Q3 24 | -20.1% | 6.8% | ||
| Q2 24 | -12.8% | 2.0% | ||
| Q1 24 | 5.2% | -5.8% |
净利率FNWBRMTI
| Q4 25 | 2.6% | -3.0% | ||
| Q3 25 | 4.8% | -11.0% | ||
| Q2 25 | 22.4% | -9.3% | ||
| Q1 25 | -51.3% | -8.0% | ||
| Q4 24 | -19.9% | -3.1% | ||
| Q3 24 | -12.5% | 5.9% | ||
| Q2 24 | -10.3% | 1.3% | ||
| Q1 24 | 2.5% | -7.6% |
每股收益（稀释后）FNWBRMTI
| Q4 25 | $0.04 | $-0.01 | ||
| Q3 25 | $0.09 | $-0.05 | ||
| Q2 25 | $0.42 | $-0.05 | ||
| Q1 25 | $-1.03 | $-0.04 | ||
| Q4 24 | $-0.31 | $-0.02 | ||
| Q3 24 | $-0.23 | $0.04 | ||
| Q2 24 | $-0.25 | $0.01 | ||
| Q1 24 | $0.04 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $10.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $157.3M | $37.0M |
| 总资产 | $2.1B | $57.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FNWBRMTI
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
股东权益FNWBRMTI
| Q4 25 | $157.3M | $37.0M | ||
| Q3 25 | $154.5M | $37.0M | ||
| Q2 25 | $149.7M | $30.4M | ||
| Q1 25 | $146.5M | $31.5M | ||
| Q4 24 | $153.9M | $32.6M | ||
| Q3 24 | $160.8M | $29.1M | ||
| Q2 24 | $158.9M | $23.5M | ||
| Q1 24 | $160.5M | $20.6M |
总资产FNWBRMTI
| Q4 25 | $2.1B | $57.1M | ||
| Q3 25 | $2.1B | $57.5M | ||
| Q2 25 | $2.2B | $52.6M | ||
| Q1 25 | $2.2B | $54.0M | ||
| Q4 24 | $2.2B | $59.2M | ||
| Q3 24 | $2.3B | $57.1M | ||
| Q2 24 | $2.2B | $53.0M | ||
| Q1 24 | $2.2B | $50.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | — | $2.2M |
| 自由现金流率自由现金流/营收 | — | 12.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | -7.22× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.2M |
8季度趋势，按日历期对齐
经营现金流FNWBRMTI
| Q4 25 | $-2.8M | $2.3M | ||
| Q3 25 | $4.7M | $-1.3M | ||
| Q2 25 | $4.0M | $1.8M | ||
| Q1 25 | $-21.7M | $-3.5M | ||
| Q4 24 | $16.9M | $865.0K | ||
| Q3 24 | $1.2M | $4.3M | ||
| Q2 24 | $8.1M | $1.4M | ||
| Q1 24 | $-4.9M | $-2.4M |
自由现金流FNWBRMTI
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | $-5.0M | $-2.5M |
自由现金流率FNWBRMTI
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | -30.9% | -11.1% |
资本支出强度FNWBRMTI
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | 0.7% | 0.6% |
现金转化率FNWBRMTI
| Q4 25 | -7.22× | — | ||
| Q3 25 | 5.89× | — | ||
| Q2 25 | 1.08× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | -12.29× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FNWB
暂无分部数据
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
